
A heart medication taken by millions is being pulled from shelves because it might contain pieces of metal sharp enough to cut you from the inside out.
Quick Take
- Breckenridge Pharmaceutical recalled one lot of Propranolol Hydrochloride Extended-Release Capsules, 60 mg, used to treat high blood pressure and related heart conditions.
- The company warns the capsules could cause cuts in the mouth, throat, stomach, or intestines.
- The recalled lot was shipped nationwide to pharmacies and wholesalers between late October and early November 2026.
- No injuries had been reported as of the announcement, and patients are told not to stop taking the drug without talking to a doctor first.
What The Company Announced
Breckenridge Pharmaceutical issued a voluntary nationwide recall of one lot of its propranolol capsules, a generic drug prescribed for high blood pressure and heart rhythm problems. The affected product comes in 100-count bottles with National Drug Code 51991-817-01, lot number PK25110035, and an expiration date of May 2029. The company says the capsules may contain metal contamination that slipped into the manufacturing process.
Breckenridge did not mince words about the danger. The company stated that using product from the affected lot “could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine”. That is a blunt way of saying a piece of metal swallowed in a pill could slice tissue anywhere from the mouth to the gut, a risk most people never think to check for in a prescription bottle.
How The Contamination Was Traced
The company linked the problem to shared production material. Breckenridge said the recalled lot used an intermediate ingredient suspected to be the source of metal contamination already found in a separate batch that never reached pharmacy shelves. In plain terms, something went wrong upstream in the manufacturing process, and the recalled lot is believed to have come from the same contaminated batch of raw material, even though it was packaged and shipped before the problem surfaced.
Adare Pharma Solutions manufactured the product for Breckenridge, though the public record does not detail exactly how the metal entered the production line or what kind of metal is involved. The recalled capsules reached wholesalers and pharmacies across the country between October 26 and November 4, 2026, meaning the window for exposure was narrow but national in reach.
What Patients And Pharmacies Are Being Told To Do
Breckenridge instructed anyone holding the affected lot to stop using it immediately and contact their doctor or pharmacist for a replacement before discontinuing treatment. That instruction matters because propranolol controls blood pressure and heart rhythm, and quitting a heart medication cold turkey can be its own health risk. Patients are urged to return unused capsules to the pharmacy rather than simply throwing them away or continuing to take them.
Pharmacies and distributors nationwide have been asked to check their inventory against the specific lot number and pull any matching stock. This kind of lot-specific recall is common practice in pharmaceutical manufacturing, allowing companies to isolate a suspected problem without pulling every bottle of a widely used drug off the market.
Why This Recall Fits A Familiar Pattern
Metal and foreign-material recalls are not rare in the drug industry. Federal recall records show repeated cases involving particles like glass, plastic, cellulose, and stainless steel turning up in injectable and oral medications over the past several years. Manufacturers are expected to act once contamination is suspected in any part of the production chain, even before every affected unit has been individually tested, which explains why Breckenridge moved on one lot tied to a shared ingredient rather than waiting for broader confirmation.
As of the announcement, no injuries or adverse health reports had been tied to the recalled capsules. That is a meaningful detail for anyone currently holding a bottle of propranolol, since it suggests the company acted on a manufacturing concern rather than responding to documented harm. Still, the company’s own words describing the potential for internal cuts are reason enough for anyone with this specific lot number to check their bottle today.
Consumers can find their lot number printed on the bottle label alongside the expiration date. Anyone unsure whether their prescription matches the recalled batch should call their pharmacy directly rather than guess, since mixing up lot numbers on a heart medication is not a risk worth taking.
đź’Š BLOOD PRESSURE MEDICATION RECALLED NATIONWIDE OVER POSSIBLE METAL CONTAMINATION
Breckenridge Pharmaceutical Inc. issued a voluntary nationwide recall for one lot of 60 mg propranolol hydrochloride extended-release capsules (lot PK25110035, expiring May 2029) over potential…
— Erik Hoffmann (@TheErikHoffmann) November 17, 2026
Patients managing high blood pressure rely on consistent, trustworthy dosing every single day. A recall like this is a reminder that even routine generic medications pass through long manufacturing chains where a single contaminated ingredient batch can ripple out to pharmacy shelves nationwide before anyone notices.
Sources:
washingtontimes.com, prnewswire.com, kmbc.com, kbtx.com, houstonchronicle.com
© conservativesense.com 2026. All rights reserved.










